Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Annals of Hematology|February 29, 2024
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe studyIngo Schwaner, Thomas Kuhn, Christoph Losem, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in AustriaGregor Aschauer, Richard Greil, Werner Linkesch, et al.
Wiener Klinische Wochenschrift|November 26, 2014
10th anniversary of the Austrian MDS Platform: aims and ongoing projectsSonja Burgstaller, Peter Bettelheim, Otto Krieger, et al.
European Journal of Clinical Investigation|October 10, 2013
Proposed score for survival of patients with myelodysplastic syndromesWolfgang R Sperr, Michael Kundi, Friedrich Wimazal, et al.
European Journal of Haematology|March 17, 2022
Multistep pathogenesis of chronic myelomonocytic leukemia in patientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
International Journal of Molecular Sciences|August 27, 2020
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic LeukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Eclinicalmedicine|November 29, 2023
BendaEAM versus BEAM as conditioning regimen for ASCT in patients with relapsed lymphoma (BEB): a multicentre, randomised, phase 2 trialFelix Keil, Antonia M S Müller, Andrea Berghold, et al.
Cancers|July 18, 2020
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like PhenotypeSonja Heibl, Bettina Gisslinger, Eva Jäger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring systemJulie Schanz, Christian Steidl, Christa Fonatsch, et al.
Blood|August 30, 2007
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsDetlef Haase, Ulrich Germing, Julie Schanz, et al.
Pageof 4